AI assistant
Cartesian Therapeutics, Inc. — Director's Dealing 2019
Dec 17, 2019
33483_dirs_2019-12-16_f25d3c05-829b-456c-820e-b25acd54d8d1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2019-12-12
Reporting Person: SPRINGER TIMOTHY A (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-12 | Common Stock | J | 1237028 | — | Acquired | 7293625 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1545576 | Indirect |
| Common Stock | 86418 | Indirect |
Footnotes
F1: On December 12, 2019, the Springer Charitable Trust (the "Trust"), a charitable remainder trust to which the reporting person is a beneficiary, made a distribution to the reporting person of 1,237,028 shares of the issuer's common stock in partial satisfaction of the Trust's obligation to pay the reporting person the remainder of the assets of the Trust and in connection with the anticipated termination of the Trust.
F2: Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.